TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26503762

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (12 IU morning and night, 24 IU per day for 5 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 31
Study: 25306681

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2-1.4 mcg/kg/hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Haloperidol (5 mg 3 times a day intramuscularly and 0.1 mg/kg intravenously)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Haloperidol with benzodiazepines
Number of subjects: 60
Study: 22858869

Group type: EXPERIMENTAL
Intervention: Individualized high-intensity rehabilitation programme (n = 43)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Usual activity (control group, n = 42)
Number of subjects: 85
Study: 20123246

Group type: EXPERIMENTAL
Intervention: AFT plus medical therapy
Number of subjects: 168

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 168
Study: 17599852

Group type: EXPERIMENTAL
Intervention: Insulin glargine (0.3 U/kg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sliding scale regular insulin (SSRI)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Intravenous insulin infusion in ICU
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Non-ICU patients treated directly with insulin glargine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall blood glucose measurements
Number of subjects: 81
Study: 15678342

Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (0.1 mmol/kg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Gd-DTPA (0.1 mmol/kg)
Number of subjects: 63
Study: 11879247

Group type: COMPARATOR
Intervention: Acetate-free biofiltration (AFB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (HDF)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both online HDF and AFB
Number of subjects: 12

Group type: COMPARATOR
Intervention: All 3 treatments
Number of subjects: 12
Study: 10094106

Group type: EXPERIMENTAL
Intervention: GH replacement therapy (n = 19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo therapy (n = 17)
Number of subjects: 36
Study: 7539121

Group type: EXPERIMENTAL
Intervention: Home intervention (HI) group (n = 64)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Clinic only group (C) (n = 66)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 2186220

Group type: EXPERIMENTAL
Intervention: Phthivazide 0.5 g three times a day for 15-20 days
Number of subjects: 540

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 540
Study: 30573719

Group type: EXPERIMENTAL
Intervention: 25 mg dexketoprofen trometamol + 8 mg thiocolchicoside
Number of subjects: 75

Group type: COMPARATOR
Intervention: 25 mg dexketoprofen trometamol
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 25 mg dexketoprofen trometamol + 4 mg thiocolchicoside
Number of subjects: 75
Study: 26661716

Group type: EXPERIMENTAL
Intervention: AEP sensors placed on the forehead
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AEP sensors placed on the nose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AEP sensors placed on the mandible
Number of subjects: 30
Study: 25923482

Group type: EXPERIMENTAL
Intervention: Cysteine-rich whey protein isolate (Immunocal®) 20 g/day
Number of subjects: 99

Group type: COMPARATOR
Intervention: Casein 20 g/day
Number of subjects: 99
Study: 23292204

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 0
Study: 21051764

Group type: EXPERIMENTAL
Intervention: Circuit Training Physical Therapy (CTPT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard Physical Therapy (SPT)
Number of subjects: 180
Study: 18580816

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham electroconvulsive therapy (sham ECT)
Number of subjects: 0
Study: 17722971

Group type: EXPERIMENTAL
Intervention: Zileuton 600mg four times daily in addition to usual asthma care
Number of subjects: 2458

Group type: COMPARATOR
Intervention: Usual asthma care only
Number of subjects: 2458
Study: 16739360

Group type: EXPERIMENTAL
Intervention: Activated charcoal
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12118641

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment during labour
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional analgesia (Control)
Number of subjects: 90
Study: 9832074

Group type: EXPERIMENTAL
Intervention: TRANS diet (trans fatty acid‐enriched diet)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: OLEIC diet (oleic acid‐enriched diet)
Number of subjects: 14
Study: 8127888

Group type: EXPERIMENTAL
Intervention: Melatonin (0.1‐10 mg, orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2672732

Group type: EXPERIMENTAL
Intervention: Sonographic evidence of a large amount of gastric fluid (greater than or equal to 5 cm2)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Sonographic evidence of little or no fluid (less than 5 cm2)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Sonographic evidence of a large amount of gastric fluid
Number of subjects: 143
Study: 324400

Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg every 12 h for 5 days)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 89
Study: 29961342

Group type: EXPERIMENTAL
Intervention: Smoking cessation group (coronary artery disease smokers)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Continuous smoking group (coronary artery disease smokers)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy non-smokers (baseline control)
Number of subjects: 58
Study: 27885840

Group type: EXPERIMENTAL
Intervention: Manidipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study: 25947184

Group type: EXPERIMENTAL
Intervention: Laughter therapy (5 times a week for 2 weeks)
Number of subjects: 64
Study: 24334198

Group type: EXPERIMENTAL
Intervention: Sexunzipped website for sexual health
Number of subjects: 22

Group type: COMPARATOR
Intervention: Information-only website
Number of subjects: 22
Study: 21262066

Group type: EXPERIMENTAL
Intervention: 100 μg of iodide (KI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 200 μg of iodide (KI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 300 μg of iodide (KI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Iodide supplement (100-300 μg/d)
Number of subjects: 30
Study: 19228612

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Coronary-artery bypass grafting (CABG)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 1800

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1800
Study: 16484106

Group type: EXPERIMENTAL
Intervention: Statements consistent with a male
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statements traditionally associated with a female
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief that the speaker was a gay male or a lesbian female
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divided attention during test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consideration of the detrimental impact of stereotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gender-neutral statements
Number of subjects: 0
Study: 12616665

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) alone or in combination with didanosine
Number of subjects: 394
Study: 10851205

Group type: EXPERIMENTAL
Intervention: Abciximab with reduced-dose thrombolysis (alteplase or reteplase)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control subjects (no AMI)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Patients with AMI
Number of subjects: 51
Study: 9089002

Group type: EXPERIMENTAL
Intervention: Mini 30 (0.03 mg levonorgestrel)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Microval (reference)
Number of subjects: 24
Study: 7903578

Group type: EXPERIMENTAL
Intervention: Active antihypertensive therapy
Number of subjects: 1627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1627
Study: 3009962

Group type: EXPERIMENTAL
Intervention: nabilone (2 X 2 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: alizapride (3 X 150 mg/day)
Number of subjects: 20
Study: 30573493

Group type: EXPERIMENTAL
Intervention: E‐SEE Steps (Incredible Years Infant book and possible group-based programmes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 0
Study: 27171108

Group type: EXPERIMENTAL
Intervention: 3% maltodextrin mouth rinse
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 6% maltodextrin mouth rinse
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 12% maltodextrin mouth rinse
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 9
Study: 23963800

Group type: EXPERIMENTAL
Intervention: Mediterranean (Med) diet enriched in MUFA with virgin olive oil
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CHO-PUFA diet (low-fat, high-carbohydrate diet enriched in n-3 PUFA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mediterranean (Med) diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CHO-PUFA diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: SFA-rich diet
Number of subjects: 20
Study: 23137509

Group type: EXPERIMENTAL
Intervention: Intramyocardial bone marrow cell (BMC) injection (100 × 10^6 BMC)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intramyocardial bone marrow cell (BMC) injection
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 16
Study: 20347835

Group type: EXPERIMENTAL
Intervention: SP6 acupressure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (rest)
Number of subjects: 40
Study: 18564727

Group type: EXPERIMENTAL
Intervention: Active gum containing 10 mg CHX, used for 20 min twice daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 15096806

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) or Stavudine (d4T)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison of ABC vs ZDV/d4T
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: On-treatment analysis for ABC arm
Number of subjects: 85

Group type: COMPARATOR
Intervention: Visceral fat accumulation, buffalo hump, self-assessed lipodystrophy, LCDS
Number of subjects: 85
Study: 12219064

Group type: EXPERIMENTAL
Intervention: PEG 3350 at 1 g/kg per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PEG 3350 at 1.5 g/kg per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PEG 3350 at 0.25 g/kg per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PEG 3350 at 0.5 g/kg per day
Number of subjects: 40
Study: 10075218

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 7867871

Group type: EXPERIMENTAL
Intervention: 60 mg 5‐isosorbide mononitrate once daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: 20 mg 5‐isosorbide mononitrate twice daily
Number of subjects: 31
Study: 2758298

Group type: EXPERIMENTAL
Intervention: Healthy subjects tapping response with preferred fixed time interval (1, 2, 3, or 4 s)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Patients tapping with the hand related to the involved hemisphere
Number of subjects: 6

Group type: COMPARATOR
Intervention: Patients tapping with either hand
Number of subjects: 6
Study: 1026547

Group type: EXPERIMENTAL
Intervention: 0-1% halcinonide cream (with neomycin and nystatin)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 1% hydrocortisone cream
Number of subjects: 50
Study: 29672368

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Bupivacaine (major surgery subgroup)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (major surgery subgroup)
Number of subjects: 128
Study: 26202101

Group type: EXPERIMENTAL
Intervention: Short-segment posterior fixation (SSPF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Long-segment posterior fixation (LLPF)
Number of subjects: 24
Study: 23823582

Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise training (WBVET)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 28
Study: 22059933

Group type: EXPERIMENTAL
Intervention: Coban 2 system applied two times per week
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Coban 2 system applied three times per week
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Coban 2 system applied five times per week
Number of subjects: 82

Group type: COMPARATOR
Intervention: Short-stretch bandaging five times per week
Number of subjects: 82
Study: 20223497

Group type: EXPERIMENTAL
Intervention: Intravenous taurolidine in crystalloid cardioplegia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo infusion of normal saline in crystalloid cardioplegia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous taurolidine in blood cardioplegia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo infusion of normal saline in blood cardioplegia
Number of subjects: 60
Study: 17905272

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Desflurane (in patients with concomitant coronary artery disease)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol (in patients with concomitant coronary artery disease)
Number of subjects: 120
Study: 16267446

Group type: EXPERIMENTAL
Intervention: External percutaneous approach
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transnasal internal lateral osteotomy (control)
Number of subjects: 50
Study: 12153370

Group type: EXPERIMENTAL
Intervention: Heart failure randomized controlled trials (RCTs)
Number of subjects: 59
Study: 10507423

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN) for 5 days, starting 24 to 48 hours after surgery
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard treatment (fluids)
Number of subjects: 63
Study: 8942456

Group type: EXPERIMENTAL
Intervention: New rating system for personality disorder severity
Number of subjects: 163

Group type: COMPARATOR
Intervention: Old rating system for personality disorder severity
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Diffuse personality disorder
Number of subjects: 163
Study: 1748135

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg ER o.d.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg o.d.
Number of subjects: 28
Study: 6817761

Group type: EXPERIMENTAL
Intervention: mesna (sodium 2-mercaptoethane sulfonate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: standard prophylactic measures
Number of subjects: 20
Study: 30888982

Group type: EXPERIMENTAL
Intervention: Muscle strengthening and balancing exercises for 10 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study: 31014546

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (updated version of a guideline-based multicomponent intervention)
Number of subjects: 12245

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (concise version of the original program)
Number of subjects: 12245

Group type: COMPARATOR
Intervention: Control group (optimized usual care)
Number of subjects: 12245

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (falls, fall-related fractures, quality of life)
Number of subjects: 12245
Study: 27670395

Group type: EXPERIMENTAL
Intervention: High cut-off serum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High cut-off dialysates
Number of subjects: 0

Group type: COMPARATOR
Intervention: High flux membrane treatment
Number of subjects: 0
Study: 26143019

Group type: EXPERIMENTAL
Intervention: PE HCl 10 mg
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: PE HCl 20 mg
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: PE HCl 30 mg
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: PE HCl 40 mg
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 25347696

Group type: EXPERIMENTAL
Intervention: Agave nectar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 22227852

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (five sets of six maximal eccentric actions of the elbow flexors)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 17
Study: 20929592

Group type: EXPERIMENTAL
Intervention: Tocotrienol rich fraction (TRF) plus tamoxifen
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo plus tamoxifen
Number of subjects: 240
Study: 17586188

Group type: EXPERIMENTAL
Intervention: Palivizumab
Number of subjects: 421

Group type: COMPARATOR
Intervention: Control (no palivizumab)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Control (not hospitalized for RSV)
Number of subjects: 421
Study: 15906759

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM) at a dose of 600 mg/24 hr
Number of subjects: 16

Group type: COMPARATOR
Intervention: Physiological solution (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Octreotide (administered to 7 patients post-study)
Number of subjects: 16
Study: 12388617

Group type: EXPERIMENTAL
Intervention: Dopaminergic therapy (dopamine-replete state)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Hypodopaminergic state (i.e., > or =12 hr after last dose of dopaminergic treatment)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 2
Study: 10445794

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 206
Study: 8775804

Group type: EXPERIMENTAL
Intervention: Saquinavir monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir combination therapy with zidovudine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir combination therapy with zidovudine and zalcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saquinavir at higher doses (2-4 times higher)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir
Number of subjects: 0
Study: 2155739

Group type: EXPERIMENTAL
Intervention: Cold compress at 0 degrees C applied bilaterally for 40 seconds
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cold compress at 120 seconds
Number of subjects: 16
Study: 6982843

Group type: EXPERIMENTAL
Intervention: Carprofen
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 10
Study: 31133067

Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agricultural extension intervention (women's groups viewing videos on nutrition-sensitive agriculture practices)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition-specific behaviour-change intervention (videos on nutrition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participatory learning and action approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-consequence analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Equity impact analysis
Number of subjects: 0
Study: 27868327

Group type: EXPERIMENTAL
Intervention: Doctor-patient communication with a focus on discussing medication themes and lifestyle treatment.
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Active patient engagement and explicit conversations about medications.
Number of subjects: 159
Study: 26319158

Group type: EXPERIMENTAL
Intervention: Reuptake inhibitor antidepressant medication (MED)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 69
Study: 24254885

Group type: EXPERIMENTAL
Intervention: EDTA chelation
Number of subjects: 633
Study: 17110396

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 138

Group type: COMPARATOR
Intervention: recombinant FSH (rFSH)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both CC and rFSH
Number of subjects: 138
Study: 15491380

Group type: EXPERIMENTAL
Intervention: Epinephrine + Dexamethasone (group 1, n=23)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Salbutamol + Dexamethasone (group 2, n=23)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Epinephrine + Placebo (group 3, n=11)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Salbutamol + Placebo (group 4, n=12)
Number of subjects: 69
Study: 11093503

Group type: EXPERIMENTAL
Intervention: Thoracoscopy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 42
Study: 9484914

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy given prior to or simultaneously with definite radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin
Number of subjects: 0
Study: 8455920

Group type: EXPERIMENTAL
Intervention: Critical Path Method (CPM) rehabilitation team
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care teams
Number of subjects: 121
Study: 3510016

Group type: EXPERIMENTAL
Intervention: Asthma Command (educational intervention by computer)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Routine computer games (control)
Number of subjects: 65
Study: 31982416

Group type: EXPERIMENTAL
Intervention: Computer-assisted motivational interviewing
Number of subjects: 232

Group type: COMPARATOR
Intervention: Educational video with counseling
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 232
Study: 30521075

Group type: EXPERIMENTAL
Intervention: SHARE (Spouses coping with the Head And neck Radiation Experience)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual Medical Care (UMC)
Number of subjects: 60
Study: 28627732

Group type: EXPERIMENTAL
Intervention: Loperamide 12 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12